Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities
Net income	$ 21,809,000	$ 18,051,000
Adjustments to reconcile net income to net cash provided by operating activities:
Net discount accretion	(5,457,000)	(7,100,000)
Depreciation and amortization expense	3,547,000	4,244,000
Provision for (recovery of) credit losses - loans	728,000	(554,000)
Recovery of credit losses - unfunded loan commitments	(376,000)	0
Share-based compensation	1,540,000	1,358,000
Gains on sales of loans originated for sale	(183,000)	(225,000)
Fair value adjustments on loans held for sale	89,000	(8,000)
Mortgage loans originated for sale	(10,054,000)	(11,225,000)
Proceeds from sales of loans originated for sale	12,872,000	12,811,000
Net gain on OREO and premises held for sale	0	(6,000)
Deferred income tax expense	2,612,000	5,766,000
Investment securities losses (gains)	2,000	(13,000)
Net losses on derivatives	27,000	180,000
Income from life insurance	(3,761,000)	(1,289,000)
Decrease (increase) in accrued interest receivable and other assets	1,042,000	(578,000)
Increase (decrease) in accrued interest payable and other liabilities	737,000	(10,805,000)
Other, net	363,000	346,000
Net cash provided by operating activities	25,537,000	10,953,000
Cash flows from investing activities
Maturities, repayments and calls of AFS securities	23,389,000	18,432,000
Purchases of AFS securities	(23,051,000)	(39,613,000)
Net purchases of restricted investments in bank stocks	2,733,000	539,000
Net (increase) decrease in loans	(38,509,000)	61,262,000
Investment in limited partnerships	(926,000)	(369,000)
Purchases of bank premises and equipment	(422,000)	(2,315,000)
Proceeds from disposal of OREO and premises held for sale	0	1,931,000
Death benefit proceeds from life insurance contracts	4,427,000	0
Net cash (used in) provided by investing activities	(32,359,000)	39,867,000
Cash flows from financing activities
Net increase in deposits	98,650,000	10,620,000
Net decrease in borrowings with original maturities less than 90 days	(48,269,000)	(2,733,000)
Proceeds from FHLB advances with original maturities greater than 90 days	95,000,000	0
Payments on FHLB advances with original maturities greater than 90 days	(120,000,000)	(15,000,000)
Dividends paid	(5,857,000)	(5,044,000)
Acquisition of treasury stock	(429,000)	0
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(970,000)	(467,000)
Proceeds from issuance of employee stock purchase plan shares	75,000	66,000
Other	(16,000)	(16,000)
Net cash provided by (used in) financing activities	18,184,000	(12,574,000)
Net increase in cash and cash equivalents	11,362,000	38,246,000
Cash and cash equivalents at beginning of period	149,774,000	248,874,000
Cash and cash equivalents at end of period	161,136,000	287,120,000
Cash paid during the period for:
Interest	25,716,000	26,643,000
Income taxes	0	0
Supplemental schedule of noncash activities:
OREO acquired in settlement of loans	1,055,000	0
Lease liabilities arising from obtaining ROU assets	$ 0	$ 831,000